Follow
Immunotherapy Open Access
Title
Cited by
Cited by
Year
Immunotherapeutic implications of IL-6 blockade for cytokine storm
T Tanaka, M Narazaki, T Kishimoto
Immunotherapy 8 (8), 959-970, 2016
7642016
Budesonide Suppresses Pulmonary Antibacterial Host Defense by Down-Regulating Cathelicidin-Related Antimicrobial Peptide
XDG Li
Immunotherapy: Open Access 2 (3), 2016
412016
Antibody therapeutics in oncology
ED Wold, VV Smider, BH Felding
Immunotherapy (Los Angeles, Calif.) 2 (1), 2016
272016
Enhancement of oncolytic activity of oHSV expressing IL-12 and anti PD-1 antibody by concurrent administration of exosomes carrying CTLA-4 miRNA
R Yan, X Zhou, X Chen, X Liu, Y Tang, J Ma, L Wang, Z Liu, B Zhan, ...
Immunotherapy 5 (154), 10.35248, 2019
162019
Pathway targeted immunotherapy: rationale and evidence of durable clinical responses with a novel, EGF-directed agent for advanced NSCLC
R Rosell, E Neninger, M Nicolson, RM Huber, S Thongprasert, PM Parikh, ...
Journal of Thoracic Oncology 11 (11), 1954-1961, 2016
152016
Chondrocyte apoptosis in rheumatoid arthritis: Is preventive therapy possible?
CJ Malemud
Immunotherapy (Los Angeles, Calif.) 1 (1), 2015
142015
Multiplex immunohistochemistry: the importance of staining order when producing a validated protocol
J Syed, J Ashton, J Joseph, GN Jones, C Slater, A Sharpe, G Ashton, ...
Immunotherapy 5 (2), 157, 2019
132019
Alzheimer’s disease of the immune system: a new variant of immune deficiency
I Melamed
Immunother Open Acc 2 (115), 2, 2016
102016
Antibody-Mediated Delivery of Antigen to Dendritic Cells
VKAR Pugholm LH
Immunotherapy: Open Access 2 (2), 10, 2016
92016
Neuroprotective effect of glial cell-derived exosomes on neurons
S Hyung, J Kim, C Yu, H Jung, J Hong
Immunotherapy 5, 156, 2019
82019
IL4I1: an emerging target to reinvigorate antitumor immune responses
F Castellano, V Molinier-Frenkel
Immunother. Open Access 3, 132-136, 2017
72017
Joint action of the nano-sized system of small non-coding RNAs with DDMC vector and recombinant IL-7 reprograms A-549 lung adenocarcinoma cells into CD4+ cells
OV Klimenko
Immunother (Los Angel.) 3, 1-6, 2017
72017
Evaluation of skin reactivity during (immuno-) therapy
S Dreborg, A Basomba, T Löfkvist, M Holgersson, C Möller
Validation of methods for estimation of changes in skin reactivity and …, 2016
72016
Identification of co-inhibitory receptors PD-1 and TIM-3 on T cells from gastric cancer patients
Y Zong, S He, F Chu, Y Jing, SA Hunsucker, T Yang
Immunother Open Acc 1 (105), 2, 2015
72015
The kynurenine/tryptophan ratio and glioblastoma patients treated with Hsppc-96 vaccine
A Lenzen, L Zhai, KL Lauing, G Gritsina, E Ladomersky, M Genet, ...
Immunotherapy (Los Angeles, Calif.) 2 (3), 2016
52016
Effect of Genetic Polymorphisms in CD14 and TLR4 on Cardiomyopathy
A Bardiaa, S Rout, SK Vishwakarma, CL Reddy, SI Ahmed, AA Khan
Immunotherapy: Open Access 2 (1), 2, 2016
42016
Evaluation of changes in skin reactivity by skin prick test titration:-
S Dreborg, M Holgersson, C Möller
Immunotherapy: open access 2 (2), 2016
32016
Atorvastatin-induced inhibition of human melanoma in vivo development
G Sarrabayrouse, I Teiti, L Filali
Immunother Open Acc 2, 111, 2016
32016
Immune Transcripts of the Pacific Oyster, Crassostrea gigas Larvae that Change in Expression as a Result of Bacteria Challenge
J Fang, X Cai, F Mao, H Li, H Chen, M Qian, JM Hambrook, PC Hanington, ...
22020
Epigenetics and Immunotherapy: New Perspective for Breaking Chronic Viral Infection
J Yan
Immunother Open Acc 2 (106), 2, 2016
22016
The system can't perform the operation now. Try again later.
Articles 1–20